Related Experiment Video
Updated: Sep 26, 2026

A Co-culture Method to Investigate the Crosstalk Between X-ray Irradiated Caco-2 Cells and PBMC
Published on: January 30, 2018
Activation of the kappa-opioid receptor in Caco-2 cells decreases interleukin-8 secretion
Brien L Neudeck1, Jennifer Loeb, Jessica Buck
1University of Wisconsin School of Pharmacy, 777 Highland Avenue, Madison, WI 53705-2222, USA. blneudeck@pharmacy
Abstract:
The immunomodulatory effects of kappa-opioid agonists at the intestinal epithelial level are not well characterized. In the present study, we determined that Caco-2 cells express the kappa-opioid receptor and its activation by trans-(+/-)-3,4-dichloro-N-methyl-N[2-(1-pyrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate (U-50488) leads to decreased interleukin-8 secretion in the presence of interleukin-1beta. These effects were detected over a wide range (10 nM-50 microM) of U-50488 concentrations and were reversible using the kappa-opioid receptor antagonist nor-binaltorphimine. Our data suggest that activation of kappa-opioid receptors on Caco-2 cells decreases interleukin-8 secretion and thus may alter the chemotactic stimulus at the epithelial level.
Insights
Kappa-opioid receptor activation on intestinal Caco-2 cells reduces interleukin-8 secretion. This finding suggests a role for kappa-opioid agonists in modulating intestinal inflammation at the epithelial level.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- The immunomodulatory impact of kappa-opioid agonists on intestinal epithelial cells remains unclear.
- Understanding these interactions is crucial for developing targeted therapies for gastrointestinal disorders.
Purpose of the Study:
- To investigate the presence and function of kappa-opioid receptors on Caco-2 cells.
- To determine the effect of kappa-opioid receptor activation on interleukin-8 secretion in intestinal epithelial cells.
Main Methods:
- Caco-2 cells were treated with the kappa-opioid agonist U-50488.
- Interleukin-8 secretion was measured in the presence of interleukin-1beta.
- Reversibility of effects was assessed using the kappa-opioid receptor antagonist nor-binaltorphimine.
Main Results:
- Caco-2 cells express the kappa-opioid receptor.
- Activation of this receptor by U-50488 significantly decreased interleukin-8 secretion.
- The observed effects were dose-dependent and reversible by nor-binaltorphimine.
Conclusions:
- Kappa-opioid receptor activation on Caco-2 cells inhibits interleukin-8 secretion.
- This mechanism may modulate the chemotactic response at the intestinal epithelial level.
- Findings suggest a potential therapeutic role for kappa-opioid agonists in intestinal inflammation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
GPCRs Regulate Adenylyl Cylase Activity
Two...
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...